UCSD CTEPH Symposium - 2019
November 15-16, 2019
IMPORTANT CME CREDIT NOTICE
CME Certificates will be issued digitally after Speaker Evaluations and Overall Surveys are completed.
Surveys are accessible after logging in with the email address you submitted during registration.
Surveys will be available online starting the day of the symposium. You must complete the process by December 9, 2019 in order to receive your certificate. Certificates will be available online until August 1, 2020
and are printable directly from the website.
The University of California San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA: The University of California San Diego School of Medicine designates this live activity for a maximum of 9.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 9.25 hours of Category 1 credit for completing this program.
Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit™ (report up to 9.25 hours of credit and list "CME Category 1" as the provider number).
Pharmacist: The California Board of Pharmacy accepts as continuing education for pharmacists coursework which meets the standard of relevance to pharmacy practice and is accepted as continuing education by the Medical Board of California.
UCSD CTEPH Symposium 2019 represents the 4th national meeting since 2014 to review the evolving landscape of chronic thromboembolic pulmonary hypertension (CTEPH) diagnosis and management. The field of CTEPH continues to garner community recognition and growing interest on an international scale. UCSD has been the world-leader in the diagnosis and treatment of CTEPH for the past 50 years. Since the previous national proceedings two years ago, our approach to patient diagnosis and treatment have further evolved. We have witnessed advances in CTEPH imaging and gathered valuable information from the ongoing US CTEPH Registry. There have been further refinements in pulmonary thromboendarterectomy surgery (PTE), additional data made available on the efficacy of both approved and investigational PH targeted therapies, and growing experience with percutaneous balloon pulmonary angioplasty (BPA). For the first time, this symposium will plan live-demonstrations of PTE and BPA. Scientific abstracts are encouraged and will be incorporated into the symposium.
At the conclusion of this program, the participant should be able to:
1) Navigate the CTEPH diagnostic algorithm for timely and accurate diagnosis
2) Recognize the importance of multidisciplinary approach to CTEPH treatment
3) Define the role and indication of each CTEPH treatments – PTE, medical therapy, BPA
4) Discuss the concept of multimodal treatment approach in CTEPH
In a relatively short period of time, there has been explosive growth in CTEPH interest from healthcare providers, scientific community, and commercial interests. Just ten years ago, we had one treatment in the form of PTE surgery for CTEPH. Now we have targeted medical therapy, percutaneous intervention with BPA, and additional ongoing investigational treatments. How these various treatment modalities apply to an individual patient with CTEPH is a point of confusion to many, even those with knowledge of CTEPH. For the individual patient, such confusion may result in significant treatment delays and/or serious adverse outcome. Additionally, and as clinicians, we have much to learn from our radiology colleagues regarding the state-of-the-art chest and vascular imaging modalities. Diagnosis of CTEPH relies heavily on imaging. Accordingly, there is a need to introduce and educate providers, engage and attract radiologists to the field, and facilitate interaction to maximize the value of our modern imaging techniques.
CTEPH state-of-the-art overview will target internists and specialists including pulmonologists, cardiologists, cardiovascular surgeons, anesthesiologists, interventionists, allied healthcare professionals and investigators in pulmonary vascular medicine.
It is the policy of the University of California San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities.
AND LINGUISTIC COMPENTENCY
This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources on cultural and linguistic competency and information about AB1195 can be found on the UCSD CME website at http://cme.ucsd.edu.